Drug Shortage Report for LOTEMAX GEL

Last updated on 2018-06-08 History
Report ID 6449
Drug Identification Number 02435853
Brand name LOTEMAX GEL
Common or Proper name LOTEMAX GEL
Company Name BAUSCH & LOMB INC
Market Status MARKETED
Active Ingredient(s) LOTEPREDNOL ETABONATE
Strength(s) 0.5%
Dosage form(s) GEL
Route of administration OPHTHALMIC
Packaging size 5
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-04-11
Estimated end date
Actual end date 2018-05-30
Shortage status Resolved
Updated date 2018-06-08
Company comments Delay in Manufacturing
Health Canada comments
Tier 3 Status No
Contact Address 1400 N GOODMAN STREET
ROCHESTER, NEW YORK
UNITED STATES 14609
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2018-06-08 French Compare
v14 2018-06-08 English Compare
v13 2018-06-02 English Compare
v12 2018-06-01 French Compare
v11 2018-06-01 English Compare
v10 2018-06-01 French Compare
v9 2018-06-01 English Compare
v8 2018-03-13 French Compare
v7 2018-03-13 English Compare
v6 2017-06-07 English Compare
v5 2017-06-02 French Compare
v4 2017-06-02 French Compare
v3 2017-06-02 English Compare
v2 2017-04-11 French Compare
v1 2017-04-11 English Compare

Showing 1 to 15 of 15